Taiho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Taiho Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5151
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group develops and markets pharmaceutical products in the field of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic agents, anti-tumor agents, H2 receptor antagonists, antibiotics and medical devices; and consumer health products such as vitamin tonic, herbal digestive medicine, topical analgesics, antifungal cream, herbal medicine powder, and others. Taiho has production facilities in Tokushima, Saitama, Okayama, Kitajima and Inuyama. It operates through its subsidiaries in Japan, China, Singapore, the UK and the US. Taiho is headquartered in Tokyo, Japan.

Taiho Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Taiho Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Taiho Pharma Acquires Fermentation Research-Related Assets from Astellas Pharma 13
Venture Financing 14
ORIC Pharma Raises USD50 Million in Series C Financing 14
Storm Therapeutics Raises Additional USD5.4 Million in Series A Financing 16
Arcus Biosciences Raises USD107 Million in Series C Financing 17
Harpoon Therapeutics Raises USD45 Million in series B Financing 19
Arcus Biosciences Raises USD70 Million in Series B Financing 21
Partnerships 22
Taiho Pharma Enters into Co-Marketing Agreement with Janssen Pharma 22
X-Chem Enters into Agreement with Taiho Pharma 23
Merck Enters into Co-Promotion Agreement with Taiho Pharma for Pembrolizumab 24
Taiho Pharma Enters into Co-Marketing Agreement with Meiji Seika Pharma 25
Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 26
Licensing Agreements 27
Taiho Pharma Enters into Licensing Agreement with Arcus Biosciences 27
TTY Biopharm Enters into Licensing Agreement with Taiho Pharma 28
Taiho Pharma Enters into Licensing Agreement with Servier 29
Taiho Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 30
Taiho Pharmaceutical Co Ltd – Key Competitors 31
Taiho Pharmaceutical Co Ltd – Key Employees 32
Taiho Pharmaceutical Co Ltd – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Strategy And Business Planning 34
Jun 02, 2017: Taiho Pharmaceutical to Construct Facility for Production of Highly Potent Pharmaceutical Ingredients 34
Mar 07, 2017: Taiho Pharmaceutical Announces Expansion into Canada 35
Product News 36
Oct 05, 2017: Taiho Pharmaceutical Releases Pitas Sore Throat Troche in Japan on October 5A Sticker-type Troche to be Placed on the Roof of the Mouth That is Helpful in Business Meetings 36
May 28, 2018: Taiho Pharmaceutical to Launch Tiovita Drink Aibitasu Zero Nationwide on May 28, 2018 “No fatigue the next day!” 37
Feb 07, 2017: Taiho Pharmaceutical Releases Pure Quick S Ointment, a New Mini Size Steroid Product 38
Clinical Trials 39
Apr 16, 2018: Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy 39
Other Significant Developments 40
Jul 03, 2018: Taiho Pharmaceutical Completes New Production Facility for Highly Potent Pharmaceutical Ingredients at Saitama Site 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Taiho Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Taiho Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Taiho Pharma Acquires Fermentation Research-Related Assets from Astellas Pharma 13
ORIC Pharma Raises USD50 Million in Series C Financing 14
Storm Therapeutics Raises Additional USD5.4 Million in Series A Financing 16
Arcus Biosciences Raises USD107 Million in Series C Financing 17
Harpoon Therapeutics Raises USD45 Million in series B Financing 19
Arcus Biosciences Raises USD70 Million in Series B Financing 21
Taiho Pharma Enters into Co-Marketing Agreement with Janssen Pharma 22
X-Chem Enters into Agreement with Taiho Pharma 23
Merck Enters into Co-Promotion Agreement with Taiho Pharma for Pembrolizumab 24
Taiho Pharma Enters into Co-Marketing Agreement with Meiji Seika Pharma 25
Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 26
Taiho Pharma Enters into Licensing Agreement with Arcus Biosciences 27
TTY Biopharm Enters into Licensing Agreement with Taiho Pharma 28
Taiho Pharma Enters into Licensing Agreement with Servier 29
Taiho Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 30
Taiho Pharmaceutical Co Ltd, Key Competitors 31
Taiho Pharmaceutical Co Ltd, Key Employees 32
Taiho Pharmaceutical Co Ltd, Subsidiaries 33

List of Figures
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Taiho Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Taiho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • InKemia IUCT Group SA (IKM):製薬・医療:M&Aディール及び事業提携情報
    Summary InKemia IUCT Group SA (InKemia IUCT), formerly Institut Univ De Ciencia i Technology SA, is a biotechnology company. The company provides research and development, technological, and consulting services. It offers customized research services. InKemia IUCT provides technology services such a …
  • NBN Co Ltd:企業の戦略的SWOT分析
    NBN Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Icagen Inc:企業の戦略的SWOT分析
    Icagen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • SK Hynix Inc (000660):企業の財務・戦略的SWOT分析
    SK Hynix Inc (000660) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Meridian Bioscience Inc (VIVO)-製薬・医療分野:企業M&A・提携分析
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, a …
  • NTT Data Corporation:企業の戦略・SWOT・財務情報
    NTT Data Corporation - Strategy, SWOT and Corporate Finance Report Summary NTT Data Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Helomics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Helomics Corp (Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Nodak Electric Cooperative, Inc.:企業の発電所・SWOT分析2018
    Nodak Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Lophius Biosciences GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets T cell-based diagnostic systems and research tools in the areas of transplantation, infectious and autoimmune diseases. The company’s T-track immunoscan assay is a test in natural or induced immune modula …
  • AMW GmbH:医療機器:M&Aディール及び事業提携情報
    Summary AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable su …
  • SCSK Corporation:企業の戦略・SWOT・財務情報
    SCSK Corporation - Strategy, SWOT and Corporate Finance Report Summary SCSK Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Larix AS-製薬・医療分野:企業M&A・提携分析
    Summary Larix A/S (Larix) is a contract research organization that offers services related to clinical trials assistance. The company provides services such as statistics, data management, clinical research, pharmacovigilance and data monitoring among others. It offers services across all phases of …
  • Frontline Ltd (FRO):石油・ガス:M&Aディール及び事業提携情報
    Summary Frontline Ltd (Frontline) is a shipping company. It transports crude oil and its related refined petroleum products. The company owns and operates very large crude carriers (VLCCs), Suezmax tankers, and Aframax/LR2 tankers. Its vessels operate in the spot and time charter markets. Frontline’ …
  • Warren Resources Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Warren Resources Inc (Warren Resources) is an oil and gas company that acquires, explores and develops crude oil and natural gas in the US. The company priovides exploration and development of waterflood oil recovery properties in the Wilmington Field in the Los Angeles Basin of California. …
  • Colonial Pipeline Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Colonial Pipeline Company (Colonial) is an oil and gas company that distributes petroleum products. The company transports refined petroleum products such as gasoline, home-heating oil, kerosene, diesel fuels; and aviation fuel including jet fuel and military fuels. It provides services incl …
  • Kot Addu Power Co Ltd:発電所・企業SWOT分析
    Kot Addu Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • MDNA Life Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and o …
  • Ryder System Inc (R):企業の財務・戦略的SWOT分析
    Ryder System Inc (R) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Matthews International Corp (MATW):企業の財務・戦略的SWOT分析
    Matthews International Corp (MATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kelly Services, Inc.:企業の戦略・SWOT・財務分析
    Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆